221 related articles for article (PubMed ID: 22863358)
1. Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson S; Maziade PJ; McFarland LV; Trick W; Donskey C; Currie B; Low DE; Goldstein EJ
Int J Infect Dis; 2012 Nov; 16(11):e786-92. PubMed ID: 22863358
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of Clostridium difficile infections with a specific probiotic combining Lactobacillus acidophilus, L. casei, and L. rhamnosus strains: assessing the evidence.
McFarland LV; Ship N; Auclair J; Millette M
J Hosp Infect; 2018 Aug; 99(4):443-452. PubMed ID: 29702133
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
Trick WE; Sokalski SJ; Johnson S; Bunnell KL; Levato J; Ray MJ; Weinstein RA
Infect Control Hosp Epidemiol; 2018 Jul; 39(7):765-770. PubMed ID: 29695310
[TBL] [Abstract][Full Text] [Related]
4. Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants.
Johnston BC; Lytvyn L; Lo CK; Allen SJ; Wang D; Szajewska H; Miller M; Ehrhardt S; Sampalis J; Duman DG; Pozzoni P; Colli A; Lönnermark E; Selinger CP; Wong S; Plummer S; Hickson M; Pancheva R; Hirsch S; Klarin B; Goldenberg JZ; Wang L; Mbuagbaw L; Foster G; Maw A; Sadeghirad B; Thabane L; Mertz D
Infect Control Hosp Epidemiol; 2018 Jul; 39(7):771-781. PubMed ID: 29695312
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms and safety of probiotics against toxigenic
Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
[TBL] [Abstract][Full Text] [Related]
6.
Dudzicz S; Kujawa-Szewieczek A; Kwiecień K; Więcek A; Adamczak M
Nutrients; 2018 Oct; 10(11):. PubMed ID: 30355985
[No Abstract] [Full Text] [Related]
7. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
McFarland LV; Johnson SB; Evans CT
Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
[TBL] [Abstract][Full Text] [Related]
8. Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies.
De Wolfe TJ; Kates AE; Barko L; Darien BJ; Safdar N
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988143
[TBL] [Abstract][Full Text] [Related]
9. Probiotics for Prevention and Treatment of Clostridium difficile Infection.
Valdés-Varela L; Gueimonde M; Ruas-Madiedo P
Adv Exp Med Biol; 2018; 1050():161-176. PubMed ID: 29383669
[TBL] [Abstract][Full Text] [Related]
10. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Bio-K+ for the prevention of
Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
[TBL] [Abstract][Full Text] [Related]
12. Probiotics for prevention of Clostridium difficile infection.
Mills JP; Rao K; Young VB
Curr Opin Gastroenterol; 2018 Jan; 34(1):3-10. PubMed ID: 29189354
[TBL] [Abstract][Full Text] [Related]
13. Use of prophylactic Saccharomyces boulardii to prevent Clostridium difficile infection in hospitalized patients: a controlled prospective intervention study.
Carstensen JW; Chehri M; Schønning K; Rasmussen SC; Anhøj J; Godtfredsen NS; Andersen CØ; Petersen AM
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1431-1439. PubMed ID: 29725956
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
[TBL] [Abstract][Full Text] [Related]
15. Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection.
De Wolfe TJ; Eggers S; Barker AK; Kates AE; Dill-McFarland KA; Suen G; Safdar N
PLoS One; 2018; 13(9):e0204253. PubMed ID: 30265691
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for primary prevention of
Fajnzylber J; Patterson W; Deshpande A
Curr Med Res Opin; 2023 Jun; 39(6):889-891. PubMed ID: 37078551
[TBL] [Abstract][Full Text] [Related]
17. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
[TBL] [Abstract][Full Text] [Related]
18. Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.
Paschos P; Ioakim K; Malandris K; Koukoufiki A; Nayfeh T; Akriviadis E; Tsapas A; Bekiari E
Anaerobe; 2021 Oct; 71():102441. PubMed ID: 34454094
[TBL] [Abstract][Full Text] [Related]
19. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Clostridium difficile Infection in Critically Ill Adults.
Leedahl DD; Personett HA; Nagpal A; Barreto EF
Pharmacotherapy; 2019 Mar; 39(3):399-407. PubMed ID: 30506900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
